ARSHIYABSEArshiya LtdMediumNeutral
Announced Tue, 19 May · 17:02 IST

Arshiya Limited has Submitted to the Exchange, the Unaudited Financial Results (Standalone) along with the Limited Review Report thereon for the Quarter ended June 30, 2024.

Going ConcernQualified OpinionEmphasis Of MatterRevenue Growth 20pctPat NegativeExceptional ItemResults View source PDF

ARSHIYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹1.20
prior close
₹1.18
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-0.8-0.8+0.0+0.0+1.7+0.8-1.7-1.7-4.2-10.8-11.7-17.5
Up moveDown movePending
AI summary

Arshiya Limited, currently under Corporate Insolvency Resolution Process (CIRP) admitted by NCLT in April 2024, has reported Q1 FY2025 results. Total income grew 31.6% year-on-year to Rs. 626.39 lakhs from Rs. 475.86 lakhs. However, the company reported a massive net loss of Rs. 99,759.94 lakhs (EPS: Rs. -37.86), primarily due to an exceptional item of Rs. 96,623.66 lakhs representing differential loan liability accounted based on lender claims. Without exceptional items, operating loss was Rs. 3,136.28 lakhs. The company's other equity stands at negative Rs. 39,853.63 lakhs. Statutory auditors ARTHA & Associates have issued a Disclaimer of Conclusion (not a standard qualified opinion) citing multiple material uncertainties: non-compliance with Ind AS 109 for corporate guarantees of Rs. 1,03,850 lakhs, failure to conduct impairment testing on PPE (Rs. 57,577.91 lakhs) and inventory (Rs. 16,505.97 lakhs), inability to verify receivables/payables, and significant operational disruption including 50 out of 71 employees resigning in August 2024 and loss of key accounting staff. Subsidiaries ANFTWZ and NCR Rail are also under CIRP, preventing consolidation.

Likely market impact

This is a highly distressed filing. The auditor's disclaimer of conclusion indicates fundamental doubts about the reliability of the financial statements. Shareholders face extreme risk given the CIRP proceedings, negative equity, massive accumulated losses, and multiple material uncertainties around asset valuations and liabilities. The stock is effectively in a speculative recovery play dependent on CIRP outcome.